| How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all … DL Murphy, MA Fox, KR Timpano, PR Moya, R Ren-Patterson, ... Neuropharmacology 55 (6), 932-960, 2008 | 272 | 2008 |
| A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder JR Wendland, PR Moya, KR Timpano, AP Anavitarte, MR Kruse, ... Archives of general psychiatry 66 (4), 408-416, 2009 | 167 | 2009 |
| A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder JR Wendland, PR Moya, MR Kruse, RF Ren-Patterson, CL Jensen, ... Human molecular genetics 17 (5), 717-723, 2008 | 151 | 2008 |
| Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT) 2A and 5-HT2C receptors PR Moya, KA Berg, MA Gutierrez-Hernandez, P Saez-Briones, ... Journal of Pharmacology and Experimental Therapeutics 321 (3), 1054-1061, 2007 | 126 | 2007 |
| Meta‐analysis of association between obsessive‐compulsive disorder and the 3′ region of neuronal glutamate transporter gene SLC1A1 SE Stewart, C Mayerfeld, PD Arnold, JR Crane, C O'dushlaine, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 162 …, 2013 | 122 | 2013 |
| Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive–compulsive disorder as an example of overlapping clinical and … DL Murphy, PR Moya, MA Fox, LM Rubenstein, JR Wendland, ... Philosophical Transactions of the Royal Society B: Biological Sciences 368 …, 2013 | 122 | 2013 |
| Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders J Spaas, L Van Veggel, M Schepers, A Tiane, J Van Horssen, ... Cellular and Molecular Life Sciences 78 (10), 4615-4637, 2021 | 114 | 2021 |
| Human serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional G× G and G× E differences in health and disease DL Murphy, PR Moya Current opinion in pharmacology 11 (1), 3-10, 2011 | 111 | 2011 |
| Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5‐HT2A and 5‐HT2C receptors C Acuña‐Castillo, C Villalobos, PR Moya, P Sáez, BK Cassels, ... British journal of pharmacology 136 (4), 510-519, 2002 | 86 | 2002 |
| miR-15a and miR-16 regulate serotonin transporter expression in human placental and rat brain raphe cells PR Moya, JR Wendland, J Salemme, RL Fried, DL Murphy International Journal of Neuropsychopharmacology 16 (3), 621-629, 2013 | 71 | 2013 |
| Rare missense neuronal cadherin gene (CDH2) variants in specific obsessive-compulsive disorder and Tourette disorder phenotypes PR Moya, NH Dodman, KR Timpano, LM Rubenstein, Z Rana, RL Fried, ... European Journal of Human Genetics 21 (8), 850-854, 2013 | 62 | 2013 |
| Lentivirally mediated GSK-3β silencing in the hippocampal dentate gyrus induces antidepressant-like effects in stressed mice N Omata, CT Chiu, PR Moya, Y Leng, Z Wang, JG Hunsberger, P Leeds, ... International Journal of Neuropsychopharmacology 14 (5), 711-717, 2011 | 60 | 2011 |
| Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder PR Moya, JR Wendland, LM Rubenstein, KR Timpano, GA Heiman, ... Movement Disorders 28 (9), 1263-1270, 2013 | 57 | 2013 |
| Increased gene expression of diacylglycerol kinase eta in bipolar disorder PR Moya, DL Murphy, FJ McMahon, JR Wendland International Journal of Neuropsychopharmacology 13 (8), 1127-1128, 2010 | 51 | 2010 |
| Altered 5-HT2C receptor agonist-induced responses and 5-HT2C receptor RNA editing in the amygdala of serotonin transporter knockout mice PR Moya, MA Fox, CL Jensen, JL Laporte, HT French, JR Wendland, ... BMC pharmacology 11, 1-9, 2011 | 48 | 2011 |
| Pharmacological identification of P2X1, P2X4 and P2X7 nucleotide receptors in the smooth muscles of human umbilical cord and chorionic blood vessels P Valdecantos, R Briones, P Moya, A Germain, JP Huidobro-Toro Placenta 24 (1), 17-26, 2003 | 44 | 2003 |
| Behavioral and synaptic alterations relevant to obsessive-compulsive disorder in mice with increased EAAT3 expression C Delgado-Acevedo, SF Estay, AK Radke, A Sengupta, AP Escobar, ... Neuropsychopharmacology 44 (6), 1163-1173, 2019 | 38 | 2019 |
| La evolución del marketing tradicional al de influencia: los influencers M Nocito, P De Moya, S Gutiérrez, B López Obtenido de https://www. unav. edu/documents/4889803/13079787/62_Orvalle+-+ …, 2017 | 36 | 2017 |
| Anti-Xa activity after enoxaparin prophylaxis in hospitalized patients weighing less than fifty-five kilograms L Rojas, A Aizman, D Ernst, MP Acuña, P Moya, R Mellado, J Cerda Thrombosis Research 132 (6), 761-764, 2013 | 28 | 2013 |
| A non-synonymous polymorphism in galactose mutarotase (GALM) is associated with serotonin transporter binding potential in the human thalamus: results of a genome-wide … X Liu, DM Cannon, N Akula, PR Moya, GM Knudsen, TE Arentzen, ... Molecular psychiatry 16 (6), 584-585, 2011 | 26 | 2011 |
Kiara R. TimpanoProfessor of Psychology, University of MiamiVerified email at miami.edu
